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Abstract
Although the mutation for myotonic dystrophy has been identified as a (CTG)n repeat expansion located in the 3P-
untranslated region of a gene located on chromosome 19, the mechanism of disease pathogenesis is not understood. The
objective of this study was to assess the effect of (CTG)n repeats on the differentiation of myoblasts in cell culture. We report
here that C2C12 myoblast cell lines permanently transfected with plasmid expressing 500 bases long CTG repeat sequences,
exhibited a drastic reduction in their ability to fuse and differentiate into myotubes. The percentage of cells fused into
myotubes in C2 C12 cells (53.4 þ 4.4%) was strikingly different from those in the two CTG repeat carrying clones (1.8 þ 0.4%
and 3.3 þ 0.7%). Control C2C12 cells permanently transfected with vector alone did not show such an effect. This finding
may have important implications in understanding the pathogenesis of congenital myotonic dystrophy. ß 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Myotonic dystrophy (DM) is an autosomal domi-
nant disease with complex multi-system involvement
[1]. The molecular basis of DM has been identi¢ed as
the expansion of a trinucleotide repeat (CTG)n lo-
cated in the 3P-untranslated region (UTR) of a
gene located on chromosome 19 [2^4]. The protein
product of this gene has strong homology to serine-
threonine protein kinases and has been termed my-
otonin protein kinase (DM-PK) [2]. Normal individ-
uals have between 3 and 37 CTG repeats, while DM
chromosomes have from 50 to several thousand re-
peats [2^5]. There is a direct correlation between the
length of the CTG repeat and the severity of clinical
symptoms [2].
The mechanism by which the DM expansion mu-
tation leads to the diverse clinical phenotype of DM
is unknown. The purpose of this study was to deter-
mine whether the DM repeat expansion itself, out-
side of the context of the DM-PK gene, was capable
of inducing any abnormality in muscle cells. This was
done by developing permanent cell lines from mouse
C2C12 cells, transfected with an expression vector
carrying CTG repeats. We report that C2C12 cells
which express CUG repeats become de¢cient in their
ability to fuse with each other or di¡erentiate into
myotubes in conditions which induce di¡erentiation
in normal cells. This ¢nding has important implica-
tions for the pathogenesis of congenital myotonic
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dystrophy as marked impairment of skeletal muscle
maturation and delayed muscle ¢ber di¡erentiation
has been described in this condition [6,7].
2. Materials and methods
2.1. Preparation of construct expressing CUG repeats
A 500-bp CTG repeat DNA fragment was ob-
tained by PCR from the DNA of a DM patient using
PCR primers (5P-CTGGAAGGGTCCTTGTAGCC-
GG-3P and 5P-ACGTCAGGGCCTCAGCCTGGC-
CGA-3P) [2], which £ank the CTG repeat region.
The PCR product obtained contains 5 bases up-
stream and 27 bases downstream of the CTG repeat.
Recognition sequences for HindIII or EcoRI were
added to the 5P-end of the two primers to permit
directional cloning. This PCR fragment was gel pu-
ri¢ed and cloned into pcDNA3 mammalian expres-
sion vector (Invitrogen, CA). Recombinant plasmids
were used to transform STBL2 cells (Life Technolo-
gies, NY) and grown overnight at 30‡C. Repeat
DNA sequences are unstable in Escherichia coli,
undergoing both deletions and expansions on repli-
cation. In order to select those clones which had
retained a CTG repeat of at least 500 bp, plasmid
DNA was extracted from ten separate clones and
analyzed by restriction digestion with HindIII and
EcoRI to release the insert and to determine which
one had retained a stable insert. Plasmid DNA with
a 500-bp insert was used further for transfection
studies.
2.2. Transfection of C2C12 cells
The mouse skeletal muscle cell line, C2C12 [8,9]
was obtained from the American Type Culture Col-
lection (Rockville, MD) and maintained routinely in
a growth medium (GM) containing high glucose (4.5
g/l) Dulbecco’s modi¢ed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum, penicillin
(100 U/ml) and streptomycin (100 Wg/ml) and kept at
37‡C in 5% CO2^95% air. All cell culture reagents
were obtained from Gibco-BRL (Grand Island, NY).
DNA transfections were performed by the calcium
phosphate precipitation technique [10]. Fifteen mi-
crograms of pcDNA3 plasmid vector (Invitrogen,
CA) or recombinant pcDNA3 containing 500-bp
CTG repeat insert were brie£y mixed with 0.5 ml
of 0.25 M CaCl2 and 0.5 ml of 2UHEPES bu¡ered
saline (280 mM NaCl, 10 mM KCl, 1.5 mM
Na2HPO4, 12 mM dextrose, 50 mM HEPES) and
incubated for about 20 min at room temperature.
The mixture was then added drop by drop to about
50% con£uent freshly fed cultures (100-mm dish, 10
ml medium) and incubated for 6 h. Cells were then
washed with GM, refed and incubated for 48 h and
then split 1:5. The transfected cells were selected for
resistant clones in GM containing 400 Wg of G418
(geneticin) per ml. Resistant clones began to appear
after 2 weeks. They were individually picked up using
cloning cylinders and expanded. They were then al-
lowed to grow but passaged before reaching about
60% con£uence to maintain the C2C12 myogenic
phenotype. G418 (400 Wg/ml) was included in the
medium throughout the culture period.
2.3. Analysis of C2C12 cells for di¡erentiation
markers
The di¡erentiation potential of G418-resistant
clones containing vector alone (two clones V1 and
V3), or vector with CTG insert (clones CTG12 and
CTG14) was compared with the parental C2C12
cells. For this purpose the cells were ¢rst grown to
con£uence in GM and the medium changed to a
di¡erentiation medium containing high glucose
DMEM and 2% horse serum for 3^7 days. The his-
tological di¡erentiation of cells was monitored as
follows.
2.4. Myosin ATPase
Cultures grown in Petri dishes were air dried for
15^30 min and then treated with the histochemical
procedure for myosin ATPase [11] or with hematox-
ylin and eosin (H and E). The cultures were then
rinsed in water and mounted in gelTol (Shandon-
Lipshaw, Pittsburg, PA).
2.5. Immunohistochemical staining
Cultures grown on gelatin-coated coverglasses
were ¢xed in methanol/acetone at 320‡C for 15
min, air dried and stored at 320‡C. For immuno-
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staining they were incubated for 15 min at room
temperature in phosphate-bu¡ered saline (PBS) con-
taining 10 mg/ml bovine serum albumin (PBS-BSA)
and treated with monoclonal antibody MF-20 which
is speci¢c for sarcomeric myosin heavy chain [12].
Thereafter, the cells were washed with PBS and in-
cubated sequentially in PBS-BSA and FITC-labeled
anti-mouse IgG (Sigma, St. Louis, MO) diluted in
PBS-BSA. After washing, the cultures were ¢xed in
4% paraformaldehyde (Sigma), washed and mounted
in Immunomount (Shandon-Lipshaw, PA). Controls
were performed by omitting MF20 and FITC-labeled
antibodies. A Zeiss epi£uorescence microscope
equipped with appropriate ¢lters and phase optics
was used for observation and photomicrography.
The hybridoma cell line used to obtain MF20 anti-
body was a kind gift from Dr. D. Fischman (Cornell
Medical Center, NY).
2.6. Determination of fusion index
To quantitate fusion of cells into myotubes, the
fusion index was calculated as the percentage of nu-
clei in myotubes (number of nuclei in myotubes/total
number of nucleiU100) in a microscopic ¢eld con-
taining about 200 cells. Five di¡erent ¢elds from
triplicate cultures of C2C12, V1, V3, CTG12 and
CTG14 cells were scored and cultures reacted with
Fig. 1. Petri dish cultures grown to con£uence in growth medium (GM) and then induced to di¡erentiate in di¡erentiation medium.
After 3 days, they were air dried and reacted for myosin ATPase; Representative cultures from (A) C2C12 cells and (B) V1 cells
show numerous positively staining myotubes (results with V3 were identical to those obtained with V1), whereas cultures from (C)
CTG12 cells and (D) CTG14 cells show only a few positively staining cells which probably represent very short myotubes. U40.
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MF20 antibody as well as those stained with H and
E were used. The fusion index from each type of
culture was expressed as mean þ S.E.M. and the sig-
ni¢cance of the di¡erences of each culture from
C2C12 cells was evaluated by t-test. Probability (P)
values of 6 0.05 were considered to be signi¢cant.
2.7. Reverse transcriptase-PCR studies
Total RNA was isolated from C2C12, V1, CTG12
and CTG14 cells growing in GM or di¡erentiation
medium for 3^4 days, using RNazol (Tel-Test, PA).
Since Northern blot detection of transcripts carrying
expanded repeats is complicated by poor detection
because of somatic heterogeneity of repeat size, we
used RT-PCR analysis instead. Isolated RNA was
treated with RNase-free DNase (Boehringer) for
15 min at 37‡C. DNase was inactivated at 75‡C for
5 min as described [13], before performing cDNA
synthesis using a cDNA cycle kit (Invitrogen, Foster
City, CA). PCR ampli¢cations were done for myo-
genin, myoD, G3PDH and (CTG)n cDNA using the
following primers [14] : myogenin, 5P-CCAGCGA-
GGGAATTTAGCTGACTC-3P and 5P-CCCTGCC-
TGTTCCCGGTATCATCA-3P ; myoD, 5P-TCTTC-
CCAACTGTCCTTTCGA-3P and 5P-GATTTCCA-
ACACCTGACTCGC-3P ; G3PDH, 5P-ACCACAG-
TCCATGCCATCAC-3P and 5P-TCCACCACCCT-
GTTGCTGTA-3P ; primers from pcDNA3 expres-
sion vector £anking 500-bp CTG repeat, 5P-CACT-
CACTATAGGGAGACC-3P and 5P-GCTGGCAA-
CTAGAAGGCACA-3P (Invitrogen, CA). Control
PCR reactions were done using RNA (after DNase
treatment), instead of cDNA as a template to exclude
the possibility of genomic DNA contamination of
RNA extracts. All PCR reactions were done at least
twice using di¡erent RNA preparations and gave
identical results. The 500-bp PCR product was eluted
from the gel and partial DNA sequence obtained as
previously described [4].
3. Results
A total of about 45 clones with parental pcDNA3
vector and 50 clones with recombinant vector carry-
ing CTG repeats were seen after G418 selection. Six
clones of transfectants with vector alone and 15 with
CTG repeats were maintained in culture for about 3
months. During this period, several CTG repeat-car-
rying clones lost their G418 resistance and could not
be maintained, suggesting instability, but two clones
described here, CTG12 and CTG14, have been pas-
saged many times and have remained stable (subse-
quent studies have shown similar results in two other
clones in which the CTG repeat is stably integrated).
These clones and the clones carrying the parental
vector alone (V1 and V3) and the wild-type C2C12
cells were maintained in identical conditions and pas-
saged to the same extent for comparison. In the GM
all were morphologically similar. However on change
to di¡erentiation medium to induce di¡erentiation,
CTG12 and CTG14 cells remained mostly as mono-
nucleate cells with only occasional small myotubes
containing three to four nuclei; on the other hand
C2C12, V1 and V3 cells di¡erentiated normally into
an extensive array of myotubes containing numerous
nuclei. The fact that all four clones carrying the CTG
repeat in a stable fashion were di¡erentiation-defec-
tive and, keeping in mind the previous observation
that di¡erentiation-defective clones spontaneously
occur only at a frequency of about 1033 [15], sug-
gests that the observed phenotype is not due to the
isolation of a spontaneous mutant clone but is an
e¡ect of the CTG repeat.
Myosin ATPase staining of cells growing in di¡er-
entiation medium for 3 days revealed some expres-
sion of myosin ATPase in a few cells (very small
myotubes) of clones CTG12 and CTG14, whereas
control C2C12, V1 and V3 cells showed large num-
bers of ATPase positive myotubes dispersed through-
out the culture (Fig. 1). Also by immunocytochemis-
try, using MF20 antibody, only a few cells from
clones CTG12 and CTG14 showed expression of my-
osin heavy chain (Fig. 2). The experiment was re-
peated three times. Each time cultures of normal
C2C12 and V1 and V3 cell lines fused to form nu-
merous myosin positive myotubes, whereas in
CTG12 and CTG14 cultures only a few myoblasts
fused into small myotubes, which never contained
more than three or four nuclei. The calculated fusion
index of C2C12 cells was 53.4 þ 4.4% and the calcu-
lated fusion indices of V1 and V3 cells were some-
what less but the di¡erence was not statistically sig-
ni¢cant (44.4 þ 4.7 and 41.4 þ 1.8 vs. 53.4 þ 4.4,
Ps 0.01). On the other hand, the fusion indices of
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Fig. 2. Coverslip cultures after 3 days in di¡erentiation medium were processed for immuno£uorescence staining with MF20 antibody
against myosin heavy chain. (A,B) C2C12, (C,D) CTG12, (E,F) CTG14. A, C and E are phase contrast ; B, D and F, are £uorescence
photographs of the same ¢elds, respectively. Numerous myosin positive myotubes are seen in C2C12 cells (B), but not in CTG12 cells
(D) or in CTG14 cells (F). The scattered myosin-positive cells in D and F appear to be single nucleated myoblasts (arrowhead, D,F)
or bi- and tri-nucleated short myotubes (arrow, D). U450.
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CTG12 and CTG14 cells were strikingly di¡erent
from C2C12 cells (1.8 þ 0.4 and 3.3 þ 0.7% vs.
53.4 þ 4.4%, P6 0.001). Cultures maintained in dif-
ferentiation medium for 6^7 days gave essentially the
same results indicating that there was an inhibition,
rather than simply a delay, in fusion and di¡erentia-
tion of CTG12 and CTG14 cells.
PCR analysis using primers from the pcDNA3
vector £anking the insert revealed the expression of
a 200-bp fragment in V1 (Fig. 3A, lane 2). Ampli¢-
cations from CTG14 (lane 3) and CTG12 (lane 4)
showed expression of the 500-bp CTG insert (a
200-bp fragment from the vector is replaced by the
500-bp CTG insert in the recombinant vector) and a
slightly smaller fragment. Sequencing of about 150
bp of the 500-bp PCR fragment con¢rmed the pres-
ence of an uninterrupted stretch of CTG repeats. The
smaller band seen in both CTG12 and CTG14 cell
lines probably represents mitotic instability which
has resulted in heterogeneity in the size of the repeat.
On studying the expression of myogenic regulatory
factors, we found that consistent with previous re-
ports [16], C2C12 cells showed myoD expression in
both proliferative and di¡erentiation conditions
whereas myogenin was expressed only in di¡erentia-
tion medium (Fig. 3B, lanes 1 and 2). Identical ex-
pression patterns were seen in RNA from V1 (Fig.
3B, lanes 7 and 8), CTG14 (Fig. 3B, lanes 3 and 4)
and CTG12 cells (Fig. 3B, lanes 5 and 6). G3PDH
was used as a control. No ampli¢cation products
were seen on using RNA as a template, showing
the absence of DNA contamination (not shown).
4. Discussion
Although the mutation responsible for myotonic
dystrophy has been identi¢ed as a CTG triplet repeat
expansion located in the 3P-untranslated region of
the DM-PK gene, the cellular consequences of the
mutation and the molecular mechanisms underlying
the development of pathology are still not under-
stood. Initial studies had suggested that alterations
in the level of DM-PK in patient tissue may be cru-
cial for the development of disease. However subse-
quent studies suggest that alterations of DM-PK
may not be the sole or most important factor under-
lying the DM phenotype because: (1) studies on the
Fig. 3. RT-PCR analysis for expression of (CUG)n RNA, myo-
genin and myoD genes. (A) Lane 1, marker; expression of
(CUG)n repeat RNA in: lane 2, V1 cells, 200-bp product, vec-
tor sequences only; lane 3, CTG14 cell line, 500-bp CTG insert
which replaces 200-bp vector fragment; lane 4, CTG12 cell line,
500-bp insert. Smaller band below the 500-bp band represents
repeat instability. (B) Expression of myoD, myogenin and
G3PDH (as control) in growth medium (GM) and di¡erentia-
tion medium after 3 days. Lane 1, C2C12 cells in GM; lane 2,
C2C12 cells in di¡erentiation medium; lane 3, CTG14 cells in
GM; lane 4, CTG14 cells in di¡erentiation medium; lane 5,
CTG12 cells in GM, lane 6, CTG12 cells in di¡erentiation me-
dium; lane 7, V1 cells in GM; lane 8, V1 cells in di¡erentiation
medium. M, marker lane.
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level of expression of DM-PK in patient tissue have
been con£icting, ¢nding decreased, unaltered, or in-
creased levels of DM-PK [17^19], probably re£ecting
the many di¡erent experimental methods and assay
systems used; and (2) studies in transgenic mice over-
expressing DM-PK develop cardiac hypertrophy,
and knockout mice without DM-PK have minimal
features suggestive of myopathy, but none of the
other features of DM [20,21]. Thus, animal models
with altered levels of DMPK do not develop the
complete DM phenotype.
In view of these ¢ndings, it has been suggested that
the CTG or CUG mutant repeat expansion may
cause pathology by secondarily a¡ecting the function
of other genes [22]. This could be by alterations in
chromatin structure caused by the CTG repeat ex-
pansion [23], resulting in decreased transcription of
neighboring genes, such as DMAHP [24,25] (DM-
associated homeodomain gene) which lies immedi-
ately downstream of the DM gene. Recent studies
on the expression of this gene in DM patient cells
and tissues have, however, been inconclusive, ¢nding
either decreased [24,25] or unaltered [26] level of
DMAHP RNA compared to normals. The other
possibility is that certain cellular proteins may be
titrated out by the expanded CTG repeat in genomic
DNA or by the expanded CUG repeat RNA, result-
ing in the disruption of important cellular processes,
such as RNA processing or nucleocytoplasmic trans-
port [27^29]. Consistent with this hypothesis, a re-
cent study has shown that the splicing of human
cardiac troponin T (cTNT) is disrupted in DM
muscle and that this e¡ect is mediated by the binding
of a heterogenous nuclear ribonucleoprotein to CUG
repeats in the cTNT premessenger RNA [30]. In ad-
dition, it has been shown that mutant DM tran-
scripts are retained in multiple foci in the nucleus
[31]. The authors suggest that the export from the
nucleus to the cytoplasm of the mutant DM tran-
script (and perhaps multiple other RNAs) may be
impeded by aberrant binding of nuclear proteins in-
volved in nucleocytoplasmic transport to the ex-
panded CUG repeat [31].
Since marked impairment of muscle cell matura-
tion and di¡erentiation is found in congenital DM
[6,7], the analysis of factors which inhibit di¡erentia-
tion in DM may provide important clues to DM
pathogenesis. It has been previously reported [32]
that di¡erentiation of myoblasts is inhibited by over-
expression of DM kinase and this inhibitory e¡ect is
mediated by a 239-bp segment in the 3P-untranslated
region of the DM transcript which excludes the CTG
repeat. The authors speculate that accumulation of
mutant DM transcripts in muscle cell nuclei, may
lead to increased binding of proteins, important for
muscle di¡erentiation, to the 3P-UTR of DM RNA.
We attempted to determine whether such an inhibi-
tory e¡ect on di¡erentiation could also be mediated
by the CTG repeat itself. We therefore studied, in
tissue culture, the e¡ect on muscle cells of carrying
and expressing randomly inserted CTG repeats,
when taken out of the context of the DM-PK gene.
We report here the development of cell lines which
promise to be fruitful for further investigations of
DM pathogenesis. We ¢nd that CTG repeats 500
bp in length (which is a length su⁄cient to cause
DM in humans) are su⁄cient to signi¢cantly inhibit
myoblast fusion and di¡erentiation of C2C12 mouse
muscle cells. The speci¢city of this e¡ect is shown by
the fact that the cell line with expression of 200 bp of
random vector sequence di¡erentiated normally.
Although other repeats besides CTG could have
been used as controls, expanded repeats have been
shown to produce multiple cellular pathologies [33].
Since they could very well result in an abnormal
cellular phenotype they were therefore not chosen
as controls for the initial studies reported here. How-
ever future studies are planned using vectors carrying
other repeats to extend and con¢rm the speci¢city of
these ¢ndings. We also anticipate that this e¡ect will
present itself in a graded manner, depending on the
degree of the CTG expansion. However, a direct
demonstration of such a correlation with the length
of the CTG repeat is complicated because of the
instability of the repeat. On reviewing the literature,
we were unable to ¢nd any other report of a CTG
repeat carrying cell line with such a phenotype.
The mechanism underlying the perturbation of the
normal process of di¡erentiation in these cell lines is
unclear. The expression of the muscle speci¢c myo-
genic regulatory factors, myogenin and myoD, which
are important in di¡erentiation and can induce the
myogenic program even in non-muscle cells, was
found to be unaltered from normal, suggesting: (1)
retention of myocytic character in the transfected
cells; and (2) possible abnormality of the cells in
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the di¡erentiation pathway, downstream of the in-
duction of the myogenic regulatory factors. We spec-
ulate that the mechanism of inhibition of di¡erentia-
tion in these cell lines is the interaction of cellular
factors with the expanded repeat at the DNA or
RNA level. Further work will be required to deter-
mine whether transcription of the CTG repeat is nec-
essary to mediate this e¡ect. Consideration of pre-
vious work [32] would indicate that such an
inhibitory e¡ect may therefore be mediated by the
abnormal binding of multiple proteins important in
di¡erentiation, either to the 3P-UTR or to the ex-
panded CUG repeat in DM RNA or to both. The
¢ndings reported here may be: (1) of relevance to the
pathogenesis of congenital DM, in which unlike DM
of adult onset, marked impairment of skeletal muscle
maturation and delayed muscle ¢ber type di¡erentia-
tion have been described [6,7]; and (2) they support
the hypothesis that alterations of DM kinase may
not be critical for the development of some aspects
of the DM phenotype.
Our work was done on C2C12 cells which are
widely used to investigate problems of muscle di¡er-
entiation; nonetheless, ¢ndings made on cell lines in
tissue culture cannot always be extended to the in
vivo situation. Several groups are attempting to de-
velop transgenic animals which carry CTG repeat
expansions in their genomes. It would be of great
interest to see whether such animals develop prob-
lems in muscle maturation. Further studies to deter-
mine the cellular factors that interact with the repeat
at the DNA and RNA level, in the cell lines we have
reported here, may shed light on the pathogenesis of
myotonic dystrophy.
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